**Company Profile: AbbVie, Inc.**

As of the 2024 Fortune ranking, AbbVie, Inc. holds the 77th position, representing a four-spot drop in the overall standings. Headquartered in North Chicago, Illinois, AbbVie is a leading player in the Health Care sector, specifically within the Pharmaceuticals industry. As a publicly traded company (NYSE: ABBV), AbbVie boasts a market capitalization of $296.7 billion as of August 5, 2024, with an updated value from the initial $322.4 billion reported on March 28, 2024.

Founded and led by a diverse management team, AbbVie is not a founder-led company, with Robert A. Michael serving as its CEO. Notably, the company does not have a female CEO. Despite being a prominent player in the pharmaceutical industry, AbbVie has not experienced growth in jobs, indicating a stabilization of its workforce.

As one of the largest companies globally, AbbVie employs approximately 50,000 people worldwide, solidifying its presence in the global market. The company's robust market presence is further underscored by its inclusion in the prestigious Fortune Global 500 list and recognition as one of the World's Most Admired Companies. Furthermore, AbbVie is acknowledged as one of the Best Companies to Work For, highlighting its commitment to employee satisfaction and well-being.

In terms of financial performance, AbbVie reported revenues of $54.3 billion, representing a 6.4% decline from the previous year. The company's profits, however, saw a more significant drop, with a 58.9% decline to $4.9 billion. Its total assets stand at $134.7 billion, demonstrating the company's substantial resources and capabilities.

As a prominent player in the pharmaceutical industry, AbbVie continues to navigate the challenges of a rapidly evolving market. Despite experiencing a decline in rank and revenue, the company remains a significant force in the global health care landscape, with a strong market presence and a reputation for excellence.